What is Dren Bio?
Dren Bio is a California-based biotechnology company leveraging advanced protein engineering to create novel therapeutic agents. Its technology is designed to target and deplete disease-causing agents, including cells and protein aggregates. The company's primary focus is on developing treatments for hematologic neoplasms and solid cancers, with ongoing research into auto-immune disorders and protein aggregation diseases. Dren Bio's strength lies in its experienced research and development team, equipped with substantial industry expertise to drive its innovative pipeline forward.
How much funding has Dren Bio raised?
Dren Bio has raised a total of $65M across 1 funding round:
Series B
$65M
Series B (2022): $65M with participation from Aisling Capital, Taiho Ventures, 8VC, HBM Healthcare Investments, Pfizer, ArrowMark Partners, Revelation Partners, and SR One
Key Investors in Dren Bio
Aisling Capital
Aisling Capital is a leading investment firm specializing in innovative healthcare products and services, with a focus on biopharmaceutical development and genomically defined cancers.
Taiho Ventures
Taiho Ventures, LLC invests in the global biotech venture community, aiming to create value and drive scientific advancements for Taiho Pharmaceutical Co., Ltd.
8VC
8VC is a technology investment firm that backs visionary teams and industry-transforming companies, with a focus on smart enterprise platforms across various sectors including healthcare and Bio-IT.
What's next for Dren Bio?
With this substantial enterprise-level funding, Dren Bio is poised to accelerate its development programs and expand its therapeutic reach. The recent strategic investment signals strong confidence from its backers in the company's technology and market potential. This capital infusion will likely fuel further clinical trials, enhance its protein engineering capabilities, and potentially broaden its research into new disease areas. Dren Bio's strategic financing positions it for significant growth and advancement in the competitive biotechnology landscape, aiming to bring its innovative therapies to patients in need.
See full Dren Bio company page
